Genetic studies of cell fusion induced by herpes simplex virus type 1.

Por Read, G S, Person, S, Keller, P M
Publicado em 1980

Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes.

Por Keller, P M, Neff, B J, Ellis, R W
Publicado em 1984

Use of a bacterial expression vector to map the varicella-zoster virus major glycoprotein gene, gC.

Por Ellis, R W, Keller, P M, Lowe, R S, Zivin, R A
Publicado em 1985

The Urinary Antibiotic 5-Nitro-8-Hydroxyquinoline (Nitroxoline) Reduces the Formation and Induces the Dispersal of Pseudomonas aeruginosa Biofilms by Chelation of Iron and Zinc

Por Sobke, A., Klinger, M., Hermann, B., Sachse, S., Nietzsche, S., Makarewicz, O., Keller, P. M., Pfister, W., Straube, E.
Publicado em 2012

Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate.

Por Furman, P A, St Clair, M H, Fyfe, J A, Rideout, J L, Keller, P M, Elion, G B
Publicado em 1979

Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolates.

Por Martin, J L, Ellis, M N, Keller, P M, Biron, K K, Lehrman, S N, Barry, D W, Furman, P A
Publicado em 1985

Metabolic activation of the nucleoside analog 9-[( 2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human diploid fibroblasts infected with human cytomegalovirus.

Por Biron, K K, Stanat, S C, Sorrell, J B, Fyfe, J A, Keller, P M, Lambe, C U, Nelson, D J
Publicado em 1985

Varicella-zoster virus as a live vector for the expression of foreign genes.

Por Lowe, R S, Keller, P M, Keech, B J, Davison, A J, Whang, Y, Morgan, A J, Kieff, E, Ellis, R W
Publicado em 1987

Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity.

Por Ellis, M N, Keller, P M, Fyfe, J A, Martin, J L, Rooney, J F, Straus, S E, Lehrman, S N, Barry, D W
Publicado em 1987

Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody.

Por Conley, A J, Kessler, J A, Boots, L J, Tung, J S, Arnold, B A, Keller, P M, Shaw, A R, Emini, E A
Publicado em 1994

New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products.

Por Davison, A J, Edson, C M, Ellis, R W, Forghani, B, Gilden, D, Grose, C, Keller, P M, Vafai, A, Wroblewska, Z, Yamanishi, K
Publicado em 1986

Successful infection of the common marmoset (Callithrix jacchus) with human varicella-zoster virus.

Por Provost, P J, Keller, P M, Banker, F S, Keech, B J, Klein, H J, Lowe, R S, Morton, D H, Phelps, A H, McAleer, W J, Ellis, R W
Publicado em 1987

Persistence of the Efficacy of Zoster Vaccine in the Shingles Prevention Study and the Short-Term Persistence Substudy

Por Schmader, K. E., Oxman, M. N., Levin, M. J., Johnson, G., Zhang, J. H., Betts, R., Morrison, V. A., Gelb, L., Guatelli, J. C., Harbecke, R., Pachucki, C., Keay, S., Menzies, B., Griffin, M. R., Kauffman, C., Marques, A., Toney, J., Keller, P. M., Li, X., Chan, I. S. F., Annunziato, P.
Publicado no Clin Infect Dis (2012)